Advancing the Design of Artificial Nano-organelles for Targeted Cellular Detoxification of Reactive Oxygen Species
Source abstract
Abstract
High Resolution Image Download MS PowerPoint Slide Artificial organelles (AnOs) are in the spotlight as systems to supplement biochemical pathways in cells. While polymersome-based artificial organelles containing enzymes to reduce reactive oxygen species (ROS) are known, applications requiring control of their enzymatic activity and cell-targeting to promote intracellular ROS detoxification are underexplored. Here, we introduce advanced AnOs where the chemical composition of the membrane supports the insertion of pore-forming melittin, enabling molecular exchange between the AnO cavity and the environment, while the encapsulated lactoperoxidase (LPO) maintains its catalytic function. We show that H 2 O 2 outside AnOs penetrates through the melittin pores and is rapidly degraded by the encapsulated enzyme. As surface attachment of cell-penetrating peptides facilitates AnOs uptake by cells, electron spin resonance revealed a remarkable enhancement in intracellular ROS detoxification by these cell-targeted AnOs compared to nontargeted AnOs, thereby opening new avenues for a significant reduction of oxidative stress in cells.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Advanced Nanomaterials in Catalysis · Nanoplatforms for cancer theranostics · Molecular Sensors and Ion Detection
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry, University of Basel, Mattenstrasse 22, 4002 Basel, Switzerland
NCCR-Molecular Systems Engineering, 4002 Basel, Switzerland
Laboratory of Applied Mechanobiology, Institute of Translational Medicine, Department of Health Sciences and Technology, ETH Zurich, 8092 Zurich, Switzerland
BioEM lab, Biozentrum, University of Basel, 4056 Basel, Switzerland
Funding
Eidgen?ssische Technische Hochschule Z?rich · Schweizerischer Nationalfonds zur F?rderung der Wissenschaftlichen Forschung · Universit?t Basel
References (28)
Show source-provided references
1. 10.2147/JIR.S27559510.2147/JIR.S275595 ↗
2. 10.1016/j.cub.2014.03.03410.1016/j.cub.2014.03.034 ↗
3. 10.1007/s11010-019-03667-910.1007/s11010-019-03667-9 ↗
4. 10.1016/j.molcel.2021.08.01810.1016/j.molcel.2021.08.018 ↗
5. 10.1038/s41573-021-00233-110.1038/s41573-021-00233-1 ↗
6. 10.1002/cbic.20200085010.1002/cbic.202000850 ↗
7. 10.1021/acscentsci.8b0033610.1021/acscentsci.8b00336 ↗
8. 10.1039/D2TB00243D10.1039/D2TB00243D ↗
9. 10.1002/btm2.1035010.1002/btm2.10350 ↗
10. 10.1002/smll.20220281810.1002/smll.202202818 ↗
11. 10.1039/D0NR07178A10.1039/D0NR07178A ↗
12. 10.1039/D1TB01463C10.1039/D1TB01463C ↗
13. 10.1021/nl401215n10.1021/nl401215n ↗
14. 10.1038/s41467-018-03560-x10.1038/s41467-018-03560-x ↗
15. 10.3390/pharmaceutics1301011610.3390/pharmaceutics13010116 ↗
16. 10.1039/D1PY00952D10.1039/D1PY00952D ↗
17. 10.1021/ma501540310.1021/ma5015403 ↗
18. 10.1016/j.ejpb.2018.09.00210.1016/j.ejpb.2018.09.002 ↗
19. 10.1073/pnas.130701011010.1073/pnas.1307010110 ↗
20. 10.1039/C4CC02780A10.1039/C4CC02780A ↗
21. 10.1007/3-540-12030-0_110.1007/3-540-12030-0_1 ↗
22. 10.1016/S0006-3495(00)76723-310.1016/S0006-3495(00)76723-3 ↗
23. 10.1016/j.freeradbiomed.2020.04.02010.1016/j.freeradbiomed.2020.04.020 ↗
24. 10.3109/10715762.2010.54024210.3109/10715762.2010.540242 ↗
25. 10.1149/2.1061908jes10.1149/2.1061908jes ↗
26. 10.3390/ijms2408724610.3390/ijms24087246 ↗
27. 10.1073/pnas.230127912010.1073/pnas.2301279120 ↗
28. 10.1016/j.apsb.2016.01.00710.1016/j.apsb.2016.01.007 ↗